Quantum News
Sign InSign Up
Back to News
research

Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Oscar Health reported Q4 and full-year 2025 earnings on February 10, 2026, with CEO Mark Bertolini and CFO Scott Blackley leading the call, highlighting financial performance and strategic updates. The company emphasized forward-looking statements under the Private Securities Litigation Reform Act of 1995, warning investors that actual results may vary due to risks outlined in their Form 10-Q filings. Analysts from major firms like Goldman Sachs, UBS, and Wells Fargo participated, signaling strong institutional interest in Oscar’s financial trajectory and market positioning. Earnings materials, including detailed results and management commentary, were made available on the company’s Investor Relations website for public and stakeholder review. The call followed standard regulatory disclosures, with operators guiding participants through procedural instructions before handing the discussion to executive leadership.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (27).png
Quantum News · Media Library

Understand this faster with AI

ChatGPTAsk ChatGPTPerplexityResearch with PerplexityClaudeExplain with ClaudeGrokDiscuss on Grok

SA Transcripts158.27K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Oscar Health, Inc. (OSCR) Q4 2025 Earnings Call February 10, 2026 8:00 AM EST Company Participants Chris Potochar - Vice President of Treasury & Investor RelationsMark Bertolini - CEO & DirectorRichard Blackley - Chief Financial Officer Conference Call Participants Joshua Raskin - Nephron Research LLCJessica Tassan - Piper Sandler & Co., Research DivisionJonathan Yong - UBS Investment Bank, Research DivisionJohn Ransom - Raymond James & Associates, Inc., Research DivisionStephen Baxter - Wells Fargo Securities, LLC, Research DivisionSamuel Becker - Goldman Sachs Group, Inc., Research DivisionRaj Kumar - Stephens Inc., Research DivisionCraig Jones - BofA Securities, Research Division Presentation Operator Good morning. My name is Jeannie, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Chris Potochar, Vice President of Treasury and Investor Relations. Chris PotocharVice President of Treasury & Investor Relations Good morning, everyone. Thank you for joining us for our fourth quarter and full year 2025 earnings call. Mark Bertolini, Oscar Health's Chief Executive Officer; and Scott Blackley, Oscar Health's Chief Financial Officer, will host this morning's call. This call can also be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release which can be found on our Investor Relations website at ir.hioscar.com. Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our quarterly report on Form 10-Q for the period ended

Read Original

Tags

quantum-finance

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.